Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
live attenuated Aujeszky's disease virus
Zoetis Belgium SA
QI09AA01
live attenuated Aujeszky's disease virus
Pigs
Immunologicals
Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus. Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus.
Revision: 15
Authorised
1998-08-07
18 B. PACKAGE LEAFLET 19 PACKAGE LEAFLET: SUVAXYN AUJESZKY 783 + O/W, LYOPHILISATE AND SOLVENT FOR EMULSION FOR INJECTION FOR PIGS 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder: Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM Manufacturer responsible for batch release: Zoetis Manufacturing & Research Spain, S.L. Ctra. de Camprodón, s/n° Finca La Riba Vall de Bianya Gerona, 17813 SPAIN 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn Aujeszky 783 + O/W, lyophilisate and solvent for emulsion for injection for pigs 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each dose (2 ml contains: Lyophilisate: ACTIVE SUBSTANCE: Live attenuated Aujeszky’s disease virus, strain NIA 3 -783 ≥ 10 5.2 CCID 50 * *CCID 50 – the quantity of virus, which infects 50 % of the cell cultures inoculated. Solvent: Aluminium hydroxide, Mineral oil (Marcol 52), Mannide mono oleate (Arlacel A), Polysorbate 80 (Tween 80), Thiomersal. Appearance of the veterinary medicinal product before reconstitution: Solvent: White, non-transparent liquid Lyophilisate: Cream coloured lyophilisate 4. INDICATION(S) Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus. Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus. Onset of immunity: 3 weeks after basic vaccination. Duration of immunity 3 months after basic vaccination. 20 5. CONTRAINDICATIONS None. 6. ADVERSE REACTIONS Slight, transient and local reactions up to 2 cm in diameter after first vaccination and up to 5 cm after second vaccination have been very commonly reported to occur in up to 50% of the pigs in laboratory studies and field trials. In general, thes Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn Aujeszky 783 + O/W, lyophilisate and solvent for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (2 ml) contains: Lyophilisate: ACTIVE SUBSTANCE: Live attenuated Aujeszky’s disease virus, strain NIA 3 -783 ≥ 10 5.2 CCID 50 * *CCID 50 – the quantity of virus, which infects 50 % of the cell cultures inoculated. Solvent: ADJUVANTS : Aluminium hydroxide 2.1 mg Mineral oil (Marcol 52) 425 µ l Mannide mono oleate (Arlacel A) 46 µ l Polysorbate 80 (Tween 80) 17 µ l EXCIPIENT: Thiomersal 0.15 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for emulsion for injection. Appearance of the veterinary medicinal product before reconstitution: Solvent: White, non-transparent liquid Lyophilisate: Cream coloured lyophilisate 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus. Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus. Onset of immunity: 3 weeks after basic vaccination. Duration of immunity: 3 months after basic vaccination. 3 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccinate healthy animals only. The presence of maternal antibodies against Aujeszky’s disease virus may have a negative influence on the result of vaccination. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Each piglet of vaccinated gilts or sows should ingest a sufficient quantity of colostrum and milk. Special precautions to be taken by the person administering the veterinary medicinal product to animals Wash and disinfect hands and Przeczytaj cały dokument